Latest Strategy Changes News

KMD Brands delivered steady sales growth and margin improvement in Q3 FY26, driven by Kathmandu and Rip Curl, while launching a business review to explore options for accelerating shareholder value.

PaySauce has successfully launched its Global Payroll Platform in Australia, targeting nearly 700,000 micro-businesses, supported by a $5 million capital raise and steady growth in its New Zealand operations.

5E Advanced Materials has requested suspension of its shares from ASX trading to enable its removal from the official list, marking a significant shift in its market presence.

Element 25 is recalibrating its US battery-grade manganese project amid evolving electric vehicle battery technologies, while maintaining focus on its Butcherbird expansion in Western Australia.

Schoolblazer Limited delivers its inaugural consolidated results following a strategic pivot to global schoolwear, posting $55.3 million revenue but a $15.2 million statutory loss amid integration and supply chain challenges.

Experience Co posted a slight decline in Q3 FY26 revenue and underlying EBITDA, weighed down by adverse weather, industrial action, and inflationary pressures, while advancing cost reductions and strategic reviews.

Pacific Nickel Mines is pressing ahead with the sale of its Kolosori Nickel Project for a nominal A$1 while remaining suspended from the ASX, supported by ongoing Glencore financing and subject to key approvals.

Savor Limited has swung back to profitability in FY26, delivering a net profit after tax of $1.3 million alongside its strongest operating margin ever at 14.5%. The hospitality group also reduced leverage significantly and is set to pay its first dividend, marking a milestone after years of losses.

Skin Elements Limited has lodged an application with the Takeovers Panel alleging undisclosed voting power exceeding 20% via a private placement, raising questions about shareholder rights ahead of critical board spill meetings.

Aguia Resources has received official commercialisation approval for its Pampafos phosphate fertiliser project, enabling invoicing and marketing ahead of a targeted sales campaign designed to boost cash flow by mid-2026.

Nexalis Therapeutics (ASX: NX1) has voluntarily suspended trading of its shares pending a material announcement on its existing debt funding facility, extending a recent trading halt. The suspension is set to last until the earlier of the announcement release or resumption of trading on 28 May 2026.

Magnetite Mines initiates a leadership overhaul and strategic reset to cut costs and pursue phased development of its Razorback Iron Ore Project amid challenging market conditions.